terix™ 10 mg comprimate filmate
ali raif ilaç sanayi a.Ş. - cetirizinum - comprimate filmate - 10 mg
tramadol-m solutie injectabila 50 mg/ml
zdorovie narodu srl, if din harkov - tramadolum - solutie injectabila - 50 mg/ml
tramadol-zn capsule 50 mg
zdorovie narodu srl, if din harkov - tramadolum - capsule - 50 mg
trifas 10 10 mg comprimate
menarini international operations luxembourg sa - torasemidum - comprimate - 10 mg
trifas 20 20 mg/4ml soluţie injectabilă
menarini international operations luxembourg sa - torasemidum - soluţie injectabilă - 20 mg/4ml
trifas 200 200 mg comprimate
menarini international operations luxembourg sa - torasemidum - comprimate - 200 mg
trifas cor 5 mg comprimate
menarini international operations luxembourg sa - torasemidum - comprimate - 5 mg
vinner-lf comprimate 5 mg
lekpharm srl - vinpocetinum - comprimate - 5 mg
vitaprost plus 20 mg + 400 mg supozitoare
nijfarm sa - samprostum + lomefloxacinum - supozitoare - 20 mg + 400 mg
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - agenți antineoplazici - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.